Conferences

October 09, 2024

Explore new CAR T and bispecific antibody strategies in myeloma care from the IMS 2024 conference, advancing treatment outcomes and patient care.

October 07, 2024

Learn about new IMS 2024 findings on high-risk multiple myeloma, evolving definitions, improved genetic testing, and cutting-edge treatment strategies.

October 04, 2024

Get the latest updates on myeloma research and treatment from the 2024 International Myeloma Society. HealthTree brings you expert interviews and key takeaways.

September 08, 2024

Discover how to manage talquetamab’s side effects with myeloma specialist Dr. Chari.

August 19, 2024

Dr. Claudio Cerchione shares multiple myeloma updates from ASCO & EHA 2024, covering novel treatments and diagnostic innovations.

August 08, 2024

Discover the results from CARTITUDE-4 subgroup analysis with Dr. Luciano Costa, for high-risk multiple myeloma patients at ASCO 2024.

July 24, 2024

Dr. Ola Landgren shares insights on bispecific antibodies and quadruple therapy for multiple myeloma at the European Hematology Association

July 10, 2024

Four-drug combinations beat three-drug combinations for newly diagnosed myeloma patients, achieving higher MRD-negative rates regardless of fitness status.

June 24, 2024

BCMA-directed CAR T cell therapy significantly improves survival outcomes in relapsed myeloma patients compared to other therapies for R/R myeloma.

June 12, 2024

Learn about the IMROZ study's promising results combining Isa-VRd which improves remissions and response rates in newly diagnosed myeloma.